Treatment of pain in cancer patients by intrathecal administration of dynorphin
- 29 January 1987
- Vol. 8 (1) , 191-193
- https://doi.org/10.1016/0196-9781(87)90186-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Dynorphin-A-(1–13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cordPeptides, 1985
- Intrathecal administration of beta-endorphin and dynorphin-(1-13) for the treatment of intractable painLife Sciences, 1985
- Analgesic effects of dynorphin-A and morphine in micePeptides, 1985
- Sites of analgesic action of dynorphinLife Sciences, 1983
- Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in ratsNeuropeptides, 1983
- Endogenous opioid peptides: review of physiological, pharmacological and clinical aspectsProgress in Neurobiology, 1982
- Dynorphin: A possible modulatory peptide on morphine or β-endorphin analgesia in mouseEuropean Journal of Pharmacology, 1981
- Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in ratsLife Sciences, 1980